John R. Toomey

1.4k total citations
25 papers, 802 citations indexed

About

John R. Toomey is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Genetics. According to data from OpenAlex, John R. Toomey has authored 25 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 9 papers in Cardiology and Cardiovascular Medicine and 7 papers in Genetics. Recurrent topics in John R. Toomey's work include Blood Coagulation and Thrombosis Mechanisms (12 papers), Platelet Disorders and Treatments (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). John R. Toomey is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (12 papers), Platelet Disorders and Treatments (8 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers). John R. Toomey collaborates with scholars based in United States, United Kingdom and Israel. John R. Toomey's co-authors include Joseph A. Erhardt, Darrel W. Stafford, Richard E. Valocik, Paul F. Koster, Kodandaram Pillarisetti, Kenneth J. Smith, George Broze, Nina Lasky, Robert N. Willette and Manuel Aivado and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

John R. Toomey

25 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Toomey United States 17 445 215 192 172 103 25 802
Christelle Nonne France 9 395 0.9× 117 0.5× 198 1.0× 63 0.4× 94 0.9× 12 620
Paolo Lova Italy 11 397 0.9× 141 0.7× 159 0.8× 85 0.5× 43 0.4× 13 631
Frauke May Germany 14 588 1.3× 239 1.1× 179 0.9× 197 1.1× 76 0.7× 17 1.1k
Crystal L. Piffath United States 6 615 1.4× 161 0.7× 218 1.1× 63 0.4× 41 0.4× 8 897
Xuesheng Feng United States 9 395 0.9× 241 1.1× 54 0.3× 186 1.1× 87 0.8× 10 721
Brenda Finney United Kingdom 13 236 0.5× 182 0.8× 77 0.4× 50 0.3× 22 0.2× 18 645
Gregory N. Adams United States 10 126 0.3× 194 0.9× 90 0.5× 135 0.8× 25 0.2× 15 550
Francis C. Chao United States 10 257 0.6× 240 1.1× 66 0.3× 67 0.4× 22 0.2× 25 630
Elizabeth J. Haining United Kingdom 13 202 0.5× 151 0.7× 77 0.4× 29 0.2× 41 0.4× 16 494
Jan‐Marcus Daniel Germany 15 92 0.2× 609 2.8× 88 0.5× 66 0.4× 12 0.1× 31 992

Countries citing papers authored by John R. Toomey

Since Specialization
Citations

This map shows the geographic impact of John R. Toomey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Toomey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Toomey more than expected).

Fields of papers citing papers by John R. Toomey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Toomey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Toomey. The network helps show where John R. Toomey may publish in the future.

Co-authorship network of co-authors of John R. Toomey

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Toomey. A scholar is included among the top collaborators of John R. Toomey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Toomey. John R. Toomey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aravindhan, Karpagam, et al.. (2021). High FGF23 Levels Failed to Predict Cardiac Hypertrophy in Animal Models of Hyperphosphatemia and Chronic Renal Failure. Journal of the Endocrine Society. 5(8). bvab066–bvab066. 3 indexed citations
2.
Ivashchenko, Christine Y., G. C. Teg Pipes, Irina M. Lozinskaya, et al.. (2013). Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype. American Journal of Physiology-Heart and Circulatory Physiology. 305(6). H913–H922. 121 indexed citations
3.
Erhardt, Joseph A., et al.. (2009). Comparative analyses of the small molecule thrombopoietin receptor agonist eltrombopag and thrombopoietin on in vitro platelet function. Experimental Hematology. 37(9). 1030–1037. 69 indexed citations
4.
Needle, Saul, Cynthia L. Burns-Kurtis, Richard E. Valocik, et al.. (2008). Antithrombotic Potential of GW813893: A Novel, Orally Active, Active-site Directed Factor Xa Inhibitor. Journal of Cardiovascular Pharmacology. 52(1). 66–71. 10 indexed citations
5.
Young, Robert J., David Brown, Cynthia L. Burns-Kurtis, et al.. (2007). Selective and dual action orally active inhibitors of thrombin and factor Xa. Bioorganic & Medicinal Chemistry Letters. 17(10). 2927–2930. 16 indexed citations
6.
Erhardt, Joseph A., et al.. (2006). P2X1 stimulation promotes thrombin receptor‐mediated platelet aggregation. Journal of Thrombosis and Haemostasis. 4(4). 882–890. 39 indexed citations
7.
Toomey, John R., Richard E. Valocik, Paul F. Koster, et al.. (2006). A comparison of the β‐D‐xyloside, odiparcil, to warfarin in a rat model of venous thrombosis. Journal of Thrombosis and Haemostasis. 4(9). 1989–1996. 31 indexed citations
8.
Zivelin, Ariella, Taketoshi Ogawa, Shlomo Bulvik, et al.. (2004). Severe factor XI deficiency caused by a Gly555 to Glu mutation (factor XI–Glu555): a cross‐reactive material positive variant defective in factor IX activation. Journal of Thrombosis and Haemostasis. 2(10). 1782–1789. 20 indexed citations
9.
Gailani, David, et al.. (2003). The Factor IX γ-Carboxyglutamic Acid (Gla) Domain Is Involved in Interactions between Factor IX and Factor XIa. Journal of Biological Chemistry. 278(10). 7981–7987. 36 indexed citations
10.
Erhardt, Joseph A., Kodandaram Pillarisetti, & John R. Toomey. (2003). Potentiation of platelet activation through the stimulation of P2X1 receptors. Journal of Thrombosis and Haemostasis. 1(12). 2626–2635. 29 indexed citations
11.
Toomey, John R., James M. Samanen, Richard E. Valocik, et al.. (2002). The Antithrombotic Efficacy of Lotrafiban (SB 214857) in Canine Models of Acute Coronary Thrombosis. PubMed. 2(1). 13–25. 5 indexed citations
12.
Erhardt, Joseph A., Eliot H. Ohlstein, John R. Toomey, et al.. (2001). Activation of Caspase-3/Caspase-3-Like Activity in Rat Cardiomyocytes by an RGD Peptide, but not the GPIIb/IIIa Antagonist Lotrafiban. Thrombosis Research. 103(2). 143–148. 14 indexed citations
13.
Toomey, John R., Michael N. Blackburn, Barbara L. Storer, et al.. (2000). Comparing the Antithrombotic Efficacy of a Humanized Anti-factor IX(a) Monoclonal Antibody (SB 249417) to the Low Molecular Weight Heparin Enoxaparin In a Rat Model of Arterial Thrombosis. Thrombosis Research. 100(1). 73–79. 30 indexed citations
14.
Feuerstein, Giora, John R. Toomey, Peter J. Bugelski, et al.. (1999). Antithrombotic Efficacy of a Novel Murine Antihuman Factor IX Antibody in Rats. Arteriosclerosis Thrombosis and Vascular Biology. 19(10). 2554–2562. 63 indexed citations
15.
Toomey, John R., et al.. (1997). Effect of tissue factor deficiency on mouse and tumor development. Proceedings of the National Academy of Sciences. 94(13). 6922–6926. 66 indexed citations
16.
Ho, Guyu, John R. Toomey, George Broze, & Alan L. Schwartz. (1996). Receptor-mediated Endocytosis of Coagulation Factor Xa Requires Cell Surface-bound Tissue Factor Pathway Inhibitor. Journal of Biological Chemistry. 271(16). 9497–9502. 30 indexed citations
17.
Toomey, John R., et al.. (1992). The endothelial cell binding determinant of human factor IX resides in the .gamma.-carboxyglutamic acid domain. Biochemistry. 31(6). 1806–1808. 29 indexed citations
18.
Toomey, John R., Kenneth J. Smith, & Darrel W. Stafford. (1991). Localization of the human tissue factor recognition determinant of human factor VIIa.. Journal of Biological Chemistry. 266(29). 19198–19202. 76 indexed citations
19.
Ware, Jerry, John R. Toomey, & Darrel W. Stafford. (1989). Epitope Localization of Anti-Factor VIII Monoclonal Antibodies Determined by Recombinant peptides. Thrombosis and Haemostasis. 61(2). 225–229. 7 indexed citations
20.
Ware, Jerry, John R. Toomey, & Darrel W. Stafford. (1988). Localization of a factor VIII-inhibiting antibody epitope to a region between residues 338 and 362 of factor VIII heavy chain.. Proceedings of the National Academy of Sciences. 85(9). 3165–3169. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christelle Nonne Breakdown of academic impact, for papers by Paolo Lova Breakdown of academic impact, for papers by Frauke May Breakdown of academic impact, for papers by Crystal L. Piffath Breakdown of academic impact, for papers by Xuesheng Feng Breakdown of academic impact, for papers by Brenda Finney Breakdown of academic impact, for papers by Gregory N. Adams Breakdown of academic impact, for papers by Francis C. Chao Breakdown of academic impact, for papers by Elizabeth J. Haining Breakdown of academic impact, for papers by Jan‐Marcus Daniel
Rankless by CCL
2026